| Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 L Swadling, MO Diniz, NM Schmidt, OE Amin, A Chandran, E Shaw, ... Nature 601 (7891), 110-117, 2022 | 376 | 2022 |
| Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma T Flecken, N Schmidt, S Hild, E Gostick, O Drognitz, R Zeiser, ... Hepatology 59 (4), 1415-1426, 2014 | 370 | 2014 |
| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 338 | 2022 |
| Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Science immunology 5 (54), eabf3698, 2020 | 212 | 2020 |
| Longevity and replenishment of human liver-resident memory T cells and mononuclear phagocytes LJ Pallett, AR Burton, OE Amin, S Rodriguez-Tajes, AA Patel, N Zakeri, ... Journal of Experimental Medicine 217 (9), 2020 | 112 | 2020 |
| IL-15 overcomes hepatocellular carcinoma-induced NK cell dysfunction NJW Easom, KA Stegmann, L Swadling, LJ Pallett, AR Burton, D Odera, ... Frontiers in immunology 9, 1009, 2018 | 94 | 2018 |
| Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma N Zakeri, A Hall, L Swadling, LJ Pallett, NM Schmidt, MO Diniz, ... Nature Communications 13 (1), 1372, 2022 | 82 | 2022 |
| Human liver memory CD8+ T cells use autophagy for tissue residence L Swadling, LJ Pallett, MO Diniz, JM Baker, OE Amin, KA Stegmann, ... Cell reports 30 (3), 687-698. e6, 2020 | 72 | 2020 |
| Targeting human Acyl-CoA: cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint NM Schmidt, PAC Wing, MO Diniz, LJ Pallett, L Swadling, JM Harris, ... Nature Communications 12 (1), 2814, 2021 | 71 | 2021 |
| Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study RK Gupta, J Rosenheim, LC Bell, A Chandran, JA Guerra-Assuncao, ... The Lancet Microbe 2 (10), e508-e517, 2021 | 67 | 2021 |
| Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy N Schmidt, C Neumann-Haefelin, R Thimme Digestive Diseases 30 (5), 483-491, 2012 | 48 | 2012 |
| Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS LJ Pallett, L Swadling, M Diniz, AA Maini, M Schwabenland, AD Gasull, ... Nature 614 (7947), 334-342, 2023 | 44 | 2023 |
| Cholesterol-modifying drugs in COVID-19 NM Schmidt, PAC Wing, JA McKeating, MK Maini Oxford open immunology 1 (1), iqaa001, 2020 | 44 | 2020 |
| T cell metabolism in chronic viral infection LJ Pallett, N Schmidt, A Schurich Clinical & Experimental Immunology 197 (2), 143-152, 2019 | 35 | 2019 |
| HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19 S Astbury, CJ Reynolds, DK Butler, DC Muñoz‐Sandoval, KM Lin, ... Immunology 166 (1), 68-77, 2022 | 30 | 2022 |
| Tumor-associated antigen specific CD8+ T cells in hepatocellular carcinoma – a promising target for immunotherapy N Schmidt, T Flecken, R Thimme Oncoimmunology 3 (9), e954919, 2014 | 28 | 2014 |
| Perspectives of immunotherapy in hepatocellular carcinoma (HCC) N Büttner, N Schmidt, R Thimme Zeitschrift für Gastroenterologie 54 (12), 1334-1342, 2016 | 24 | 2016 |
| Role of immunity in pathogenesis and treatment of hepatocellular carcinoma N Schmidt, R Thimme Digestive Diseases 34 (4), 429-437, 2016 | 24 | 2016 |
| Hepatocellular carcinoma-from immunobiology to immunotherapy T Flecken, N Schmidt, HC Spangenberg, R Thimme Zeitschrift fur Gastroenterologie 50 (1), 47-56, 2012 | 13 | 2012 |
| Somatostatinoma--the most recently described pancreatic islet cell tumor. C Reynolds, R Pratt, C Chan-Yan, W Boyko, W MacDonald, N Schmidt, ... Western Journal of Medicine 142 (3), 393, 1985 | 13 | 1985 |
